In this study, the author explored the role of interferon regulatory factor 7 (IRF7) and latent membrane protein 1 (LMP1) on the regulation of antigen presenting molecules in B-lymphoblastoid cell lines. First, the author observed the endogenous expression of IRF7 and LMP1 in paired EBV-positive B-lymphoblastoid cell lines, Sav I and Sav III, which represent EBV type I and type III latency, respectively. The Sav I cell, which does not express LMP1, showed very low levels of endogenous IRF7 in the cytoplasm. However, Sav III cells, which express large amounts of LMP1, contained high levels of endogenous IRF7 in both the cytoplasm and the nucleus. The expression of surface MHC class I antigen was 7.8-fold higher in Sav III compared with Sav I cells when measured by fluorescence activated cell sorter (FACS) analysis. To understand whether IRF7 is involved in regulation of MHC I and TAP1, LMP1 or IRF7 were expressed by cotransfection in DG75 cells. Levels of TAP1 protein were up-regulated by LMP1 and IRF7 alone, and by LMP1 co expression with IRF7, the expression level was highest after co-transfection of LMP1 with IRF7. TAP1 promoter activity was also up-regulated to 2.4, 2.0, 3.2-fold by LMP1, by IRF7, and by LMP1 plus IRF7, respectively. Surface expression of MHC class I antigen was up-regulated by LMP1 alone and LMP1 plus IRF7, but not by IRF7 alone. These results suggest that IRF7 induces the expression of TAP1, but not MHC class I antigen and that LMP1 and IRF7 have additive effects on the expression of TAP1 protein.
Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K: Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93: 10990-10995, 1996
Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 77: 339-349, 1993.
Nonkwelo C, Ruf IK, Sample J: Interferon-independent and -induced regulation of Epstein-Barr Virus EBNA-1 gene transcription in Burkitt lymphoma. J Viro 71: 6887-6897, 1997
Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of pep-tide transporters and HLA-class I antigen expression. Eur J Immunol 25:1374-1384, 1995.
Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779, 1996
Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP: Coordinate regulation of the human TAPI and LMP2 genes from a shared bidirectional promoter. J Exp Med 181: 1459-1471, 1995
Zhang L, Pagano JS: IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell BioI 17: 5748-5757, 1997
Zhang L, Pagano JS: Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. J Virol 75: 341-350, 2001
Gregory CD, Rowe M, Rickinson AB: Different Epstein- Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71: 1481-1495, 1990
Ning SB, Hahn AM, Huye L, Pagano JS: Interferon Regulatory Factor 7 Regulates Expression of EpsteinBarr Virus Latent Membrane Protein 1: A Regulatory Circuit J Virol 77: 9359-9368, 2003
Nguyen H, Hiscott J, Pitha PM: The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 8: 293-312, 1997
Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322, 1991
Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T: Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548, 2000
Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T: Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971-974, 1993
Min W, Pober JS, Johnson DR: Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN- gamma signaltransduction pathways. Circ Res 83: 815-823, 1998
Yeow WS, Au WC, Juaug YT, Fields CD, Dent CL, Gewert DR, Pitha PM: Reconstitution of virus-mediated expression of interferon alpha genes in human fibroblast cells by ectopic interferon regulatory factor-7. J BioI Chem 275: 6313-6320, 2000
Au WC, Moore PA, Lowther W, Juang YT, Pitha PM: Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci USA 92: 11657-11661, 1995
Coscoy L, Ganem D: Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97: 8051-8056, 2000.
Rowe DT, Rowe M, Evan GI, Wallace LE, Farrell PJ, Rickinson AB: Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells. EMBO J 5: 2599-2607, 1986
Sandberg M, Hammerschmidt W, Sugden B: Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol 71: 4649-4656, 1997
Seliger B, Hammers S, Hohne A, Zeidler R, Knuth A, Gerharz CD, Huber C: IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma. Clin Cancer Res 3: 573-578, 1997
Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ: Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 163: 1428-1434, 1999
Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739, 1989
Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH: A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18: 1081-1091, 1999
Rickinson AB, Kieff E: Epstein Barr virus, pp 2599-2612. In Fields Virology, 4th ed. Lippincott William & Wilkins, Philadelphia, 2001
Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G: Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte trans-formation: role in NF-kappaB activation. Mol Cell Biol 16: 7098-7108, 1996.
Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Ki-mura Y, Taniguchi T: Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO 7: 3397-3405,1988.
Ishido S, Wang C, Lee BS, Cohen GB, Jung JU: Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300-5309, 2000
Marie I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO 17: 6660-6669, 1998
Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ: Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci USA 97: 8455-8460, 2000
Kirchhoff S, Schaper F, Hauser H: Interferon regu-latory factor 1 (IRF-1)mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acid Res 21: 2889, 1993.
Zhang L, Pagano JS: Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol 74: 1061-1068, 2000
Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM, Bentwich Z, Ramot B, Klein E, Klein G: Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19: 27-33, 1977
Boname JM, de Lima BD, Lehner PJ, Stevenson PG: Viral degradation of the MHC class I peptide loading complex. Immunity 20: 305-317, 2004
Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL: Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93:11327-11333, 1996.
Kieff E, Rickinson AB: Epstein Barr virus and its replication, pp 2519-2541. In Fields Virology, 4th ed. Lippincott William & Wilkins, Philadelphia, 2001
Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak TW, Taniguchi T: Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924, 1994
Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Fruh K: Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120, 2004
Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM: Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273: 29210-29271, 1998.
Johnson DR: Locus-specific constitutive and cytokineinduced HLA class I gene expression. J Immuol 170: 1894-1902, 2003
Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW, Taniguchi: Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839, 1994
Young LS, Dawson CW, Clark D, Rupani H, Busson P, Thrsz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69: 1051-1065, 1988
Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer S42: 329-338, 1988.
Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688, 1995